Follow
Nuria Malats
Nuria Malats
Senior Group Leader
Verified email at cnio.es
Title
Cited by
Cited by
Year
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire
M Gumá, A Angulo, C Vilches, N Gómez-Lozano, N Malats, ...
Blood 104 (12), 3664-3671, 2004
9312004
A consensus molecular classification of muscle-invasive bladder cancer
A Kamoun, A de Reyniès, Y Allory, G Sjödahl, AG Robertson, R Seiler, ...
European urology 77 (4), 420-433, 2020
9102020
Prognosis Research Strategy (PROGRESS) 2: prognostic factor research
RD Riley, JA Hayden, EW Steyerberg, KGM Moons, K Abrams, PA Kyzas, ...
PLoS medicine 10 (2), e1001380, 2013
7972013
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
M García-Closas, N Malats, D Silverman, M Dosemeci, M Kogevinas, ...
The Lancet 366 (9486), 649-659, 2005
7582005
Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools
CM Villanueva, KP Cantor, JO Grimalt, N Malats, D Silverman, A Tardon, ...
American journal of epidemiology 165 (2), 148-156, 2007
7232007
Detectable clonal mosaicism and its relationship to aging and cancer
KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ...
Nature genetics 44 (6), 651-658, 2012
6612012
Comprehensive transcriptional analysis of early-stage urothelial carcinoma
J Hedegaard, P Lamy, I Nordentoft, F Algaba, S Høyer, BP Ulhøi, S Vang, ...
Cancer cell 30 (1), 27-42, 2016
5782016
EphB receptor activity suppresses colorectal cancer progression
E Batlle, J Bacani, H Begthel, S Jonkeer, A Gregorieff, M Van De Born, ...
Nature 435 (7045), 1126-1130, 2005
5092005
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
N Rothman, M Garcia-Closas, N Chatterjee, N Malats, X Wu, JD Figueroa, ...
Nature genetics 42 (11), 978-984, 2010
5032010
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, ...
Journal of Clinical Oncology 15 (8), 2866-2872, 1997
4471997
Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas
S Hernández, E López-Knowles, J Lloreta, M Kogevinas, A Amorós, ...
Journal of Clinical Oncology 24 (22), 3664-3671, 2006
3922006
Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage
M Porta, X Fabregat, N Malats, L Guarner, A Carrato, A De Miguel, L Ruiz, ...
Clinical and Translational Oncology 7, 189-197, 2005
3862005
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
N Malats, A Bustos, CM Nascimento, F Fernandez, M Rivas, D Puente, ...
The lancet oncology 6 (9), 678-686, 2005
3712005
Epidemiology of urinary bladder cancer: from tumor development to patient’s death
C Murta-Nascimento, BJ Schmitz-Dräger, MP Zeegers, G Steineck, ...
World journal of urology 25, 285-295, 2007
3552007
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
BM Wolpin, C Rizzato, P Kraft, C Kooperberg, GM Petersen, Z Wang, ...
Nature genetics 46 (9), 994-1000, 2014
3362014
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
C Balbás-Martínez, A Sagrera, E Carrillo-de-Santa-Pau, J Earl, ...
Nature genetics 45 (12), 1464-1469, 2013
3192013
Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome
Y Allory, W Beukers, A Sagrera, M Flández, M Marqués, M Márquez, ...
European urology 65 (2), 360-366, 2014
2982014
PIK3CA Mutations Are an Early Genetic Alteration Associated with FGFR3 Mutations in Superficial Papillary Bladder Tumors
E López-Knowles, S Hernández, N Malats, M Kogevinas, J Lloreta, ...
Cancer research 66 (15), 7401-7404, 2006
2842006
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis
H Witt, M Sahin-Tóth, O Landt, JM Chen, T Kähne, JPH Drenth, Z Kukor, ...
Nature genetics 38 (6), 668-673, 2006
2842006
Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study
LE Moore, RM Pfeiffer, C Poscablo, FX Real, M Kogevinas, D Silverman, ...
The lancet oncology 9 (4), 359-366, 2008
2792008
The system can't perform the operation now. Try again later.
Articles 1–20